stockrowEnvista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.
- Revenue
- +3.22%
- EPS
- +1,855.6%
- Free cash flow
- −6.48%
- Total debt
- −1.13%
Quarter to September 2026, against a year earlier
Follow NVST
Alert me
Envista Holdings Corporation (NVST) Total debt
Envista Holdings Corporation's total debt at the end of fiscal 2025 was $1.4B, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $1.4B. Over the past ten years it has ranged from $1.3B (fiscal 2021) to $1.8B (fiscal 2020); the current reading is higher than 71% of that period. Envista Holdings Corporation ranks 11th of 50 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $1.4B | 3.87% |
| FY2024 | $1.4B | (7.87%) |
| FY2023 | $1.5B | 9.61% |
| FY2022 | $1.4B | 4.93% |
| FY2021 | $1.3B | (26.68%) |
| FY2020 | $1.8B | 35.44% |
| FY2019 | $1.3B | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $1.4B | (0.51%) |
| Jun 2026 | $1.4B | (0.19%) |
| Mar 2026 | $1.4B | (0.64%) |
| Dec 2025 | $1.4B | 0.20% |
| 25 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| TFX Teleflex Incorporated compare | $2.8B |
| NVST Envista Holdings Corporation | $1.4B |
| ICUI ICU Medical, Inc. compare | $1.2B |
| MMSI Merit Medical Systems, Inc. compare | $737.4M |
| STVN Stevanato Group S.p.A. compare | $545.0M |
| WRBY Warby Parker Inc. compare | $170.2M |
| ATRC AtriCure, Inc. compare | $61.0M |
| PLSE Pulse Biosciences, Inc compare | $9.4M |
| MMED MiniMed Group, Inc. compare | — |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on NVST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement